301569 · Novast Laboratories, Limited · Financials
Market Cap
16.79B CNY
Shares
891.60M
Volume · Nov 9
31.01M
Avg daily vol (5 sessions)
59.72M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
895.47M
+3.4%
FY2025
Net Income
227.82M
-12.4%
FY2025
Operating Margin
29.35%
-4.2pp
FY2025
Operating Cash Flow
322.58M
+20.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| CNY | 895.47M | 866.22M | 700.43M |
| CNY | 262.83M | 290.62M | 137.4M |
| CNY | 263.13M | 290.08M | 136.13M |
| CNY | 35.31M | 29.93M | 20.34M |
| CNY | 227.82M | 260.15M | 115.79M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.